CIK 0000885590
- Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- Operating
- Phone
- +1 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- 4 Grant or award Pres&Co-Head Bausch&Lomb/Int'l acquired 90,260 shares (grant or award)
- 4 Shares withheld for taxes President, Salix gave up 1,278 shares (to pay taxes)
- 4 Shares withheld for taxes EVP AND GENERAL COUNSEL gave up 5,017 shares (to pay taxes)
- 4 Open-market buy Director bought 1,400 shares at $25.94 ($36,316)
- 4 Open-market buy Director bought 10,000 shares at $25.01 ($250,123)
- 4 Grant or award Director acquired 234 shares (grant or award)
- 4 Grant or award Director acquired 1,300 shares (grant or award)
- 4 Grant or award Director acquired 1,044 shares (grant or award)
- 4 Grant or award Director acquired 1,044 shares (grant or award)
- 4 Grant or award Director acquired 1,044 shares (grant or award)
- 4 Grant or award Director acquired 1,172 shares (grant or award)
- 4 Open-market sale EVP & Chief Financial Officer sold 17,000 shares at $31.68 ($538,586)
- 4 Open-market sale EVP AND GENERAL COUNSEL sold 121,198 shares at $31.83 ($3,857,732)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award EVP & Chief Financial Officer acquired 33,673 shares (grant or award)
- 4 Open-market sale Director sold 11,037 shares at $31.79 ($350,811)
- 4 Grant or award Director acquired 7,645 shares (grant or award)
- 4 Grant or award Director acquired 7,645 shares (grant or award)
- 4 Grant or award Director acquired 7,645 shares (grant or award)
- 4 Grant or award Director acquired 7,645 shares (grant or award)
Page 14 of 61 · 1,214 filings